Skip to main content
Erschienen in: Heart and Vessels 3/2023

28.09.2022 | Original Article

Association between major adverse cardiovascular events and pentraxin-3 in patients who have undergone coronary computed tomography angiography: from the FU-CCTA registry

verfasst von: Natsuki Ohnishi, Yuhei Shiga, Kohei Tashiro, Yuto Kawahira, Yuuka Shibata, Hiroko Inoue, Joji Morii, Hiroaki Nishikawa, Yuta Kato, Takashi Kuwano, Makoto Sugihara, Shin-ichiro Miura

Erschienen in: Heart and Vessels | Ausgabe 3/2023

Einloggen, um Zugang zu erhalten

Abstract

Chronic vasculitis is considered to be associated with future cardiovascular events. Here, we present major cardiovascular events (MACEs) in patients who underwent coronary computed tomography angiography (CCTA) for screening for coronary artery disease (CAD), and the association between MACEs and the inflammation marker pentraxin (PTX)-3 or highly sensitive C-reactive protein (hsCRP). The patients who underwent CCTA for the purpose of screening for CAD at Fukuoka University Hospital (FU-CCTA registry), 456 patients with suspected CAD or at least one cardiovascular risk factor were followed for up to 5 years. The levels of PTX-3 and hsCRP in blood were measured at the time of CCTA, and the patients were divided into two groups according to the presence (MACEs group) or absence (non-MACEs group) of MACEs. There were no differences in PTX-3 or hsCRP between the MACEs (−) and MACEs ( +) groups in all patients. A multivariate analysis related to the presence or absence of MACEs by logistic regression analysis of inflammation factors (PTX-3 and hsCRP) in addition to conventional risk factors as independent variables was performed. PTX-3 was a predictor of MACEs in males, whereas smoking, but not PTX-3, was a predictor of MACEs in females. PTX-3 could be a predictor of MACEs in males, but not females.
Literatur
1.
Zurück zum Zitat Ristagno G, Fumagalli F, Bottazzi B, Mantovani A, Olivari D, Novelli D, Latini R (2019) Pentraxin 3 in cardiovascular disease. Front Immunol 10:823CrossRef Ristagno G, Fumagalli F, Bottazzi B, Mantovani A, Olivari D, Novelli D, Latini R (2019) Pentraxin 3 in cardiovascular disease. Front Immunol 10:823CrossRef
2.
Zurück zum Zitat Matsuura Y, Hatakeyama K, Imamura T, Tsuruda T, Shibata Y, Kodama T, Kitamura K, Asada Y (2012) Different distribution of pentraxin 3 and C-reactive protein in coronary atherosclerotic plaques. J Atheroscler Thromb 19:837–845CrossRef Matsuura Y, Hatakeyama K, Imamura T, Tsuruda T, Shibata Y, Kodama T, Kitamura K, Asada Y (2012) Different distribution of pentraxin 3 and C-reactive protein in coronary atherosclerotic plaques. J Atheroscler Thromb 19:837–845CrossRef
3.
Zurück zum Zitat Norata GD, Marchesi P, Venu VKP, Pasqualini F, Anselmo A, Moalli F, Pizzitola I, Garlanda C, Mantovani A, Catapano AL (2009) Deficiency of the long pentraxin PTX3 promotes vascular inflammation and atherosclerosis. Circulation 120:699–708CrossRef Norata GD, Marchesi P, Venu VKP, Pasqualini F, Anselmo A, Moalli F, Pizzitola I, Garlanda C, Mantovani A, Catapano AL (2009) Deficiency of the long pentraxin PTX3 promotes vascular inflammation and atherosclerosis. Circulation 120:699–708CrossRef
4.
Zurück zum Zitat Inoue K, Sugiyama A, Reid PC, Ito Y, Miyauchi K, Mukai S, Sagara M, Miyamoto K, Satoh H, Kohno I, Kurata T, Ota H, Mantovani A, Hamakubo T, Daida H, Kodama T (2007) Establishment of a high sensitivity plasma assay for human pentraxin3 as a marker for unstable angina pectoris. Arterioscler Thromb Vasc Biol 27:161–167CrossRef Inoue K, Sugiyama A, Reid PC, Ito Y, Miyauchi K, Mukai S, Sagara M, Miyamoto K, Satoh H, Kohno I, Kurata T, Ota H, Mantovani A, Hamakubo T, Daida H, Kodama T (2007) Establishment of a high sensitivity plasma assay for human pentraxin3 as a marker for unstable angina pectoris. Arterioscler Thromb Vasc Biol 27:161–167CrossRef
5.
Zurück zum Zitat Iwata A, Miura S, Tanaka T, Ike A, Sugihara M, Nishikawa H, Kawamura A, Saku K (2012) Plasma pentraxin-3 levels are associated with coronary plaque vulnerability and are decreased by statin. Coron Artery Dis 23:315–321CrossRef Iwata A, Miura S, Tanaka T, Ike A, Sugihara M, Nishikawa H, Kawamura A, Saku K (2012) Plasma pentraxin-3 levels are associated with coronary plaque vulnerability and are decreased by statin. Coron Artery Dis 23:315–321CrossRef
6.
Zurück zum Zitat Nakamura A, Miura S, Shiga Y, Norimatsu K, Miyase Y, Suematsu Y, Mitsutake R, Saku K (2014) Is pentraxin 3 a biomarker, a player, or both in the context of coronary atherosclerosis and metabolic factors? Heart Vessels 30:752–761CrossRef Nakamura A, Miura S, Shiga Y, Norimatsu K, Miyase Y, Suematsu Y, Mitsutake R, Saku K (2014) Is pentraxin 3 a biomarker, a player, or both in the context of coronary atherosclerosis and metabolic factors? Heart Vessels 30:752–761CrossRef
7.
Zurück zum Zitat Higashi S, Shiga Y, Yano M, Imaizumi T, Tashiro K, Idemoto Y, Kato Y, Kuwano T, Sugihara M, Miura S (2020) Associations between smoking habits and major adverse cardiovascular events in patients who underwent coronary computed tomography angiography as screening for coronary artery disease. Heart Vessel 36:483–491CrossRef Higashi S, Shiga Y, Yano M, Imaizumi T, Tashiro K, Idemoto Y, Kato Y, Kuwano T, Sugihara M, Miura S (2020) Associations between smoking habits and major adverse cardiovascular events in patients who underwent coronary computed tomography angiography as screening for coronary artery disease. Heart Vessel 36:483–491CrossRef
8.
Zurück zum Zitat Yano M, Miura S, Shiga Y, Miyase Y, Suematsu Y, Norimatsu K, Nakamura A, Adachi S, Nishikawa H, Saku K (2016) Association between smoking habits and severity of coronary stenosis as assessed by coronary computed tomography angiography. Heart Vessel 31:1061–1068CrossRef Yano M, Miura S, Shiga Y, Miyase Y, Suematsu Y, Norimatsu K, Nakamura A, Adachi S, Nishikawa H, Saku K (2016) Association between smoking habits and severity of coronary stenosis as assessed by coronary computed tomography angiography. Heart Vessel 31:1061–1068CrossRef
9.
Zurück zum Zitat Shibata Y, Shiga Y, Suematsu Y, Tashiro K, Kawahira Y, Morita K, Kuwano T, Sugihara M, Miura S (2021) Association between major adverse cardiovascular events and the ratio of subcutaneous fat area to visceral fat area in patients who have undergone multidetector row computed tomography. Circ Rep 3:674–681CrossRef Shibata Y, Shiga Y, Suematsu Y, Tashiro K, Kawahira Y, Morita K, Kuwano T, Sugihara M, Miura S (2021) Association between major adverse cardiovascular events and the ratio of subcutaneous fat area to visceral fat area in patients who have undergone multidetector row computed tomography. Circ Rep 3:674–681CrossRef
10.
Zurück zum Zitat Inoue H, Shiga Y, Norimatsu K, Tashiro K, Futami M, Suematsu Y, Sugihara M, Nishikawa H, Katsuda Y, Miura S (2021) Associations between high-density lipoprotein functionality and major adverse cardiovascular events in patients who have undergone coronary computed tomography angiography. J Clin Med 10:2431CrossRef Inoue H, Shiga Y, Norimatsu K, Tashiro K, Futami M, Suematsu Y, Sugihara M, Nishikawa H, Katsuda Y, Miura S (2021) Associations between high-density lipoprotein functionality and major adverse cardiovascular events in patients who have undergone coronary computed tomography angiography. J Clin Med 10:2431CrossRef
11.
Zurück zum Zitat Kawahira Y, Shiga Y, Inoue H, Suematsu Y, Tashiro K, Kato Y, Fujimi K, Takamiya Y, Kuwano T, Sugihara M, Miura S (2021) Association between high-density lipoprotein cholesterol levels and major adverse cardiovascular events in patients who underwent coronary computed tomography angiography: FU-CCTA registry. Heart Vessel 36:1457–1465CrossRef Kawahira Y, Shiga Y, Inoue H, Suematsu Y, Tashiro K, Kato Y, Fujimi K, Takamiya Y, Kuwano T, Sugihara M, Miura S (2021) Association between high-density lipoprotein cholesterol levels and major adverse cardiovascular events in patients who underwent coronary computed tomography angiography: FU-CCTA registry. Heart Vessel 36:1457–1465CrossRef
12.
Zurück zum Zitat Chu Y, Teng J, Feng P, Liu H, Wang F, Li X (2019) Pentraxin-3 in coronary artery disease: a meta-analysis. Cytokine 119:197–201CrossRef Chu Y, Teng J, Feng P, Liu H, Wang F, Li X (2019) Pentraxin-3 in coronary artery disease: a meta-analysis. Cytokine 119:197–201CrossRef
13.
Zurück zum Zitat Mitsutake R, Niimura H, Miura S, Zhang B, Iwata A, Nishikawa H, Kawamura A, Kumagai K, Shirai K, Matsunaga A, Saku K (2006) Clinical signifcance of the coronary calcifcation score by multidetector row computed tomography for the evaluation of coronary stenosis in Japanese patients. Circ J 70:1122–1127CrossRef Mitsutake R, Niimura H, Miura S, Zhang B, Iwata A, Nishikawa H, Kawamura A, Kumagai K, Shirai K, Matsunaga A, Saku K (2006) Clinical signifcance of the coronary calcifcation score by multidetector row computed tomography for the evaluation of coronary stenosis in Japanese patients. Circ J 70:1122–1127CrossRef
14.
Zurück zum Zitat Ueda Y, Shiga Y, Idemoto Y, Tashiro K, Motozato K, Koyoshi R, Kuwano T, Fujimi K, Ogawa M, Saku K, Miura S (2018) Association between the presence or severity of coronary artery disease and pericardial fat, paracardial fat, epicardial fat, visceral fat, and subcutaneous fat as assessed by multi-detector row computed tomography. Int Heart J 59:695–704CrossRef Ueda Y, Shiga Y, Idemoto Y, Tashiro K, Motozato K, Koyoshi R, Kuwano T, Fujimi K, Ogawa M, Saku K, Miura S (2018) Association between the presence or severity of coronary artery disease and pericardial fat, paracardial fat, epicardial fat, visceral fat, and subcutaneous fat as assessed by multi-detector row computed tomography. Int Heart J 59:695–704CrossRef
15.
Zurück zum Zitat Gensini GG (1983) A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 51:606CrossRef Gensini GG (1983) A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 51:606CrossRef
16.
Zurück zum Zitat Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R (1990) Quantifcation of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15:827–832CrossRef Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R (1990) Quantifcation of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15:827–832CrossRef
17.
Zurück zum Zitat Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, Horio T, Hoshide S, Ikeda S, Ishimitsu T, Ito M, Ito S, Iwashima Y, Kai H, Kamide K, Kanno Y, Kashihara N, Kawano Y, Kikuchi T, Kitamura K, Kitazono T, Kohara K, Kudo M, Kumagai H, Matsumura K, Matsuura H, Miura K, Mukoyama M, Nakamura S, Ohkubo T, Ohya Y, Okura T, Rakugi H, Saitoh S, Shibata H, Shimosawa T, Suzuki H, Takahashi S, Tamura K, Tomiyama H, Tsuchihashi T, Ueda S, Uehara Y, Urata H, Hirawa N (2019) The Japanese society of hypertension guidelines for the management of hypertension (JSH 2019). Hypertens Res 42:1235–1481CrossRef Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, Horio T, Hoshide S, Ikeda S, Ishimitsu T, Ito M, Ito S, Iwashima Y, Kai H, Kamide K, Kanno Y, Kashihara N, Kawano Y, Kikuchi T, Kitamura K, Kitazono T, Kohara K, Kudo M, Kumagai H, Matsumura K, Matsuura H, Miura K, Mukoyama M, Nakamura S, Ohkubo T, Ohya Y, Okura T, Rakugi H, Saitoh S, Shibata H, Shimosawa T, Suzuki H, Takahashi S, Tamura K, Tomiyama H, Tsuchihashi T, Ueda S, Uehara Y, Urata H, Hirawa N (2019) The Japanese society of hypertension guidelines for the management of hypertension (JSH 2019). Hypertens Res 42:1235–1481CrossRef
18.
Zurück zum Zitat Kinoshita M, Yokote K, Arai H, Iida M, Ishigaki Y, Ishibashi S, Umemoto S, Egusa G, Ohmura H, Okamura T, Kihara S, Koba S, Saito I, Shoji T, Daida H, Tsukamoto K, Deguchi J, Dohi S, Dobashi K, Hamaguchi H, Hara M, Hiro T, Biro S, Fujioka Y, Maruyama C, Miyamoto Y, Murakami Y, Yokode M, Yoshida H, Rakugi H, Wakatsuki A, Yamashita S (2018) Committee for epidemiology and clinical management of atherosclerosis, the Japan atherosclerosis society. Japan atherosclerosis society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017. J Atheroscler Thromb 25:846–984CrossRef Kinoshita M, Yokote K, Arai H, Iida M, Ishigaki Y, Ishibashi S, Umemoto S, Egusa G, Ohmura H, Okamura T, Kihara S, Koba S, Saito I, Shoji T, Daida H, Tsukamoto K, Deguchi J, Dohi S, Dobashi K, Hamaguchi H, Hara M, Hiro T, Biro S, Fujioka Y, Maruyama C, Miyamoto Y, Murakami Y, Yokode M, Yoshida H, Rakugi H, Wakatsuki A, Yamashita S (2018) Committee for epidemiology and clinical management of atherosclerosis, the Japan atherosclerosis society. Japan atherosclerosis society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017. J Atheroscler Thromb 25:846–984CrossRef
19.
Zurück zum Zitat American Diabetes Association (2004) Screening for type 2 diabetes. Diabetes Care 27:S11-14CrossRef American Diabetes Association (2004) Screening for type 2 diabetes. Diabetes Care 27:S11-14CrossRef
20.
Zurück zum Zitat Sobhani K, Nieves Castro DK, Fu Q, Gottlieb RA, Van Eyk JE, Noel Bairey Merz C (2018) Sex differences in ischemic heart disease and heart failure biomarkers. Biol Sex Differ 9:43CrossRef Sobhani K, Nieves Castro DK, Fu Q, Gottlieb RA, Van Eyk JE, Noel Bairey Merz C (2018) Sex differences in ischemic heart disease and heart failure biomarkers. Biol Sex Differ 9:43CrossRef
21.
Zurück zum Zitat Nicholls SJ, Hsu A, Wolski K, Hu B, Bayturan O, Lavoie A, Uno K, Tuzcu EM, Nissen SE (2010) Intravascular ultrasound-derived measures of coronary atherosclerotic plaque burden and clinical outcome. J Am Coll Cardiol 55:2399–2407CrossRef Nicholls SJ, Hsu A, Wolski K, Hu B, Bayturan O, Lavoie A, Uno K, Tuzcu EM, Nissen SE (2010) Intravascular ultrasound-derived measures of coronary atherosclerotic plaque burden and clinical outcome. J Am Coll Cardiol 55:2399–2407CrossRef
22.
Zurück zum Zitat Cattaneo MG, Banfi C, Brioschi M, Lattuada D, Vicentini LM (2021) Sex-dependent differences in the secretome of human endothelial cells. Biol Sex Differ 12:7CrossRef Cattaneo MG, Banfi C, Brioschi M, Lattuada D, Vicentini LM (2021) Sex-dependent differences in the secretome of human endothelial cells. Biol Sex Differ 12:7CrossRef
23.
Zurück zum Zitat Yamasaki K, Kurimura M, Kasai T, Sagara M, Kodama T, Inoue K (2009) Determination of physiological plasma pentraxin 3 (PTX3) levels in healthy populations. Clin Chem Lab Med 47:471–477CrossRef Yamasaki K, Kurimura M, Kasai T, Sagara M, Kodama T, Inoue K (2009) Determination of physiological plasma pentraxin 3 (PTX3) levels in healthy populations. Clin Chem Lab Med 47:471–477CrossRef
24.
Zurück zum Zitat Lee R, Ahn HR, Shin MH, Kim HN, Lee YH, Choi SW, Kweon SS (2019) Association of plasma pentraxin-3 level with lipid levels and cardiovascular risk factors in people with no history of lipid-lowering medication: the dong-gu study. J Atheroscler Thromb 26:738–745CrossRef Lee R, Ahn HR, Shin MH, Kim HN, Lee YH, Choi SW, Kweon SS (2019) Association of plasma pentraxin-3 level with lipid levels and cardiovascular risk factors in people with no history of lipid-lowering medication: the dong-gu study. J Atheroscler Thromb 26:738–745CrossRef
25.
Zurück zum Zitat Zebrack JS, Muhlestein JB, Horne BD, Anderson JL (2002) C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina. J Am Coll Cardiol 39:632–637CrossRef Zebrack JS, Muhlestein JB, Horne BD, Anderson JL (2002) C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina. J Am Coll Cardiol 39:632–637CrossRef
26.
Zurück zum Zitat Meuwissen M, Winter RJ, Chamuleau SAJ, Heijne M, Koch KT, Berg A, Straalen JP, Bax M, Schorborgh CE, Kearney D, Sanders GT, Tijssen JGP, Piek JJ (2003) Value of C-reactive protein in patients with stable angina pectoris, coronary narrowing (30 to 70%), and normal fractional flow reserve. Am J Cardiol 92:702–705CrossRef Meuwissen M, Winter RJ, Chamuleau SAJ, Heijne M, Koch KT, Berg A, Straalen JP, Bax M, Schorborgh CE, Kearney D, Sanders GT, Tijssen JGP, Piek JJ (2003) Value of C-reactive protein in patients with stable angina pectoris, coronary narrowing (30 to 70%), and normal fractional flow reserve. Am J Cardiol 92:702–705CrossRef
27.
Zurück zum Zitat Jha P, Ramasundarahettige C, Landsman V, Rostron B, Thun M, Anderson RN, McAfee T, Peto R (2013) 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med 368:341–350CrossRef Jha P, Ramasundarahettige C, Landsman V, Rostron B, Thun M, Anderson RN, McAfee T, Peto R (2013) 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med 368:341–350CrossRef
28.
Zurück zum Zitat Huxley RR, Woodward M (2011) Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies. Lancet 378:1297–1305CrossRef Huxley RR, Woodward M (2011) Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies. Lancet 378:1297–1305CrossRef
29.
Zurück zum Zitat Michnovicz JJ, Hershcopf RJ, Naganuma H, Bradlow HL, Fishman J (1986) Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking. N Engl J Med 315:1305–1309CrossRef Michnovicz JJ, Hershcopf RJ, Naganuma H, Bradlow HL, Fishman J (1986) Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking. N Engl J Med 315:1305–1309CrossRef
30.
Zurück zum Zitat Njølstad I, Arnesen E, Lund-Larsen PG (1996) Smoking, serum lipids, blood pressure, and sex differences in myocardial infarction. a 12-year follow-up of the finnmark study. Circulation 93:450–456CrossRef Njølstad I, Arnesen E, Lund-Larsen PG (1996) Smoking, serum lipids, blood pressure, and sex differences in myocardial infarction. a 12-year follow-up of the finnmark study. Circulation 93:450–456CrossRef
Metadaten
Titel
Association between major adverse cardiovascular events and pentraxin-3 in patients who have undergone coronary computed tomography angiography: from the FU-CCTA registry
verfasst von
Natsuki Ohnishi
Yuhei Shiga
Kohei Tashiro
Yuto Kawahira
Yuuka Shibata
Hiroko Inoue
Joji Morii
Hiroaki Nishikawa
Yuta Kato
Takashi Kuwano
Makoto Sugihara
Shin-ichiro Miura
Publikationsdatum
28.09.2022
Verlag
Springer Japan
Erschienen in
Heart and Vessels / Ausgabe 3/2023
Print ISSN: 0910-8327
Elektronische ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-022-02171-3

Weitere Artikel der Ausgabe 3/2023

Heart and Vessels 3/2023 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.